A detailed history of Goldman Sachs Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,650,450 shares of LLY stock, worth $3.7 Billion. This represents 0.68% of its overall portfolio holdings.

Number of Shares
4,650,450
Previous 4,927,940 5.63%
Holding current value
$3.7 Billion
Previous $4.46 Billion 7.66%
% of portfolio
0.68%
Previous 0.77%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $214 Million - $266 Million
-277,490 Reduced 5.63%
4,650,450 $4.12 Billion
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $296 Million - $371 Million
408,381 Added 9.04%
4,927,940 $4.46 Billion
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $95 Million - $127 Million
-160,374 Reduced 3.43%
4,519,559 $3.52 Billion
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $83.6 Million - $98.5 Million
-159,123 Reduced 3.29%
4,679,933 $2.73 Billion
Q3 2023

May 14, 2024

BUY
$434.7 - $599.3 $69.2 Million - $95.4 Million
159,123 Added 3.4%
4,839,056 $2.6 Billion
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $311,245 - $429,098
-716 Reduced 0.01%
4,839,056 $2.6 Billion
Q2 2023

May 14, 2024

SELL
$350.74 - $468.98 $296 Million - $396 Million
-845,234 Reduced 14.87%
4,839,772 $2.27 Billion
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $296 Million - $396 Million
-845,234 Reduced 14.87%
4,839,772 $2.27 Billion
Q1 2023

May 14, 2024

BUY
$310.63 - $364.82 $263 Million - $309 Million
847,845 Added 17.53%
5,685,006 $1.95 Billion
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $263 Million - $309 Million
847,845 Added 17.53%
5,685,006 $1.95 Billion
Q4 2022

May 14, 2024

BUY
$321.55 - $374.67 $22.8 Million - $26.6 Million
70,963 Added 1.49%
4,837,161 $1.77 Billion
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $22.8 Million - $26.6 Million
70,963 Added 1.49%
4,837,161 $1.77 Billion
Q3 2022

May 14, 2024

BUY
$296.48 - $337.87 $27.2 Million - $31 Million
91,654 Added 1.96%
4,766,198 $1.54 Billion
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $27.2 Million - $31 Million
91,654 Added 1.96%
4,766,198 $1.54 Billion
Q2 2022

May 14, 2024

SELL
$278.73 - $327.27 $1.5 Million - $1.76 Million
-5,389 Reduced 0.12%
4,674,544 $1.52 Billion
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $50.4 Million - $59.2 Million
180,850 Added 4.02%
4,674,544 $1.52 Billion
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $49 Million - $60.9 Million
208,962 Added 4.88%
4,493,694 $1.29 Billion
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $106 Million - $132 Million
-471,398 Reduced 9.91%
4,284,732 $1.18 Billion
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $1.05 Billion - $1.3 Billion
4,756,130 New
4,756,130 $1.1 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.